Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.

[1]  R. Verma,et al.  Genetics of bladder cancer , 1996, Journal of Molecular Medicine.

[2]  P. Esposti,et al.  The role of exfoliative cytology in the management of bladder carcinoma , 2004, Urological Research.

[3]  P. Sprent.  Statistics in medical research. , 2003, Swiss medical weekly.

[4]  R. Simon,et al.  Patterns of chromosomal imbalances in muscle invasive bladder cancer. , 2000, International journal of oncology.

[5]  D. Jacqmin,et al.  Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. , 2000, Cancer research.

[6]  A. Crisci,et al.  Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  D. Kobayashi,et al.  Limitations of urinary telomerase activity measurement in urothelial cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[8]  M. Toublanc,et al.  Absence of microsatellite instability in transitional cell carcinoma of the bladder. , 2000, Urology.

[9]  F. Rousseau,et al.  Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31 , 1999, Oncogene.

[10]  O. Cussenot,et al.  Assessment of microsatellite instability in urine in the detection of transitional‐cell carcinoma of the bladder , 1998, International journal of cancer.

[11]  S. Kyo,et al.  Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  T. Ørntoft,et al.  Molecular alterations in bladder cancer , 1998, Urological Research.

[13]  I. Arzimanoglou,et al.  Microsatellite instability in human solid tumors , 1998, Cancer.

[14]  David Sidransky,et al.  Detection of bladder cancer recurrence by microsatellite analysis of urine , 1997, Nature Medicine.

[15]  Kathleen R. Cho,et al.  Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.

[16]  T. Polascik,et al.  Novel suppressor loci on chromosome 14q in primary bladder cancer. , 1995, Cancer research.

[17]  K. Kinzler,et al.  Mismatch repair deficiency in phenotypically normal human cells , 1995, Science.

[18]  S. Brewster,et al.  Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. , 1994, British Journal of Cancer.

[19]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[20]  S. Loening,et al.  Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.